HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mamoru Ito Selected Research

Enzymes

11/2018Epithelial-mesenchymal transition is activated in CD44-positive malignant ascites tumor cells of gastrointestinal cancer.
6/2006Ontogenetic characteristics of enzyme activities and plasma metabolites in C57BL/6J:Jcl mice deficient in insulin receptor substrate 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mamoru Ito Research Topics

Disease

40Neoplasms (Cancer)
05/2024 - 05/2003
13Infections
05/2024 - 08/2003
8Stomach Neoplasms (Stomach Cancer)
05/2024 - 10/2018
7Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 11/2017
6Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
06/2014 - 11/2002
5Febrile Neutropenia
05/2024 - 02/2024
5Melanoma (Melanoma, Malignant)
01/2022 - 01/2012
5Neoplasm Metastasis (Metastasis)
01/2022 - 10/2007
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 08/2006
4Hypersensitivity (Allergy)
01/2021 - 07/2005
4Thrombocytopenia (Thrombopenia)
01/2020 - 08/2008
4Acquired Immunodeficiency Syndrome (AIDS)
01/2013 - 02/2005
3Disease Progression
03/2024 - 10/2018
3Graft vs Host Disease (Graft-Versus-Host Disease)
01/2019 - 06/2009
3Body Weight (Weight, Body)
01/2019 - 09/2006
3Leukemia
01/2014 - 08/2006
3Insulin Resistance
01/2011 - 06/2006
3Glucose Intolerance
01/2011 - 06/2006
2Chemotherapy-Induced Febrile Neutropenia
05/2024 - 04/2024
2Neutropenia
04/2024 - 03/2024
2Lung Neoplasms (Lung Cancer)
02/2024 - 12/2019
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2022 - 01/2011
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
10/2022 - 09/2018
2Carcinoma (Carcinomatosis)
01/2022 - 01/2020
2Sarcoma (Soft Tissue Sarcoma)
10/2021 - 12/2020
2Head and Neck Neoplasms (Head and Neck Cancer)
10/2021 - 01/2021
2Squamous Cell Carcinoma of Head and Neck
01/2021 - 01/2018
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2019 - 10/2007
2Ischemia
11/2019 - 01/2011
2Inflammation (Inflammations)
01/2019 - 11/2018
2Hyperplasia
11/2018 - 03/2002
2Ascites
11/2018 - 09/2018
2Glioblastoma (Glioblastoma Multiforme)
10/2017 - 01/2017
2Hypoxia (Hypoxemia)
08/2015 - 01/2011
2Pathologic Constriction (Stenosis)
02/2014 - 01/2003
2Virus Diseases (Viral Diseases)
01/2008 - 01/2007
2Leukemic Infiltration
01/2006 - 05/2003
2T-Cell Leukemia (Leukemia, T Cell)
01/2006 - 05/2003
1Heart Failure
04/2024
1Neuroendocrine Carcinoma
04/2024
1Prostatic Neoplasms (Prostate Cancer)
03/2024
1Musculoskeletal Pain
03/2024
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2024
1Hypophysitis
11/2023
1Renal Cell Carcinoma (Grawitz Tumor)
11/2023
1Rhabdomyosarcoma
10/2023

Drug/Important Bio-Agent (IBA)

9Granulocyte Colony-Stimulating Factor (G-CSF)IBA
05/2024 - 02/2024
5NivolumabIBA
01/2023 - 01/2020
5Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2007
4CytokinesIBA
11/2018 - 06/2003
3Biomarkers (Surrogate Marker)IBA
11/2023 - 09/2018
3Immune Checkpoint InhibitorsIBA
11/2023 - 09/2018
3Monoclonal AntibodiesIBA
10/2021 - 09/2006
3Immunoglobulin E (IgE)IBA
01/2021 - 06/2003
3LigandsIBA
10/2020 - 03/2003
3Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020 - 06/2017
3AntibodiesIBA
12/2019 - 01/2007
3AntigensIBA
11/2018 - 01/2012
3Interleukin Receptor Common gamma SubunitIBA
06/2014 - 02/2005
3NF-kappa B (NF-kB)IBA
08/2005 - 05/2003
2Therapeutic UsesIBA
05/2024 - 06/2014
2HLA-DR Antigens (HLA-DR)IBA
11/2021 - 01/2014
2eribulinFDA Link
10/2021 - 12/2020
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021 - 03/2003
2SteroidsIBA
10/2021 - 08/2015
2C-Reactive ProteinIBA
01/2021 - 12/2018
2Lactoglobulins (beta-Lactoglobulin)FDA Link
01/2021 - 01/2015
2Doxorubicin (Adriamycin)FDA LinkGeneric
12/2020 - 05/2017
2Immune Checkpoint ProteinsIBA
10/2020 - 12/2019
2Bevacizumab (Avastin)FDA Link
01/2020 - 11/2017
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2020 - 06/2018
2STX-0119IBA
12/2019 - 10/2017
2Fluorouracil (Carac)FDA LinkGeneric
11/2019 - 06/2017
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
11/2018 - 09/2013
2Interleukin-13IBA
11/2018 - 06/2003
2EnzymesIBA
11/2018 - 06/2006
2Immunoglobulin G (IgG)IBA
11/2018 - 01/2017
2Immunoglobulins (Immunoglobulin)IBA
09/2018 - 02/2014
2Interleukin-6 (Interleukin 6)IBA
01/2018 - 08/2005
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 07/2004
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2015 - 01/2012
2Glucose (Dextrose)FDA LinkGeneric
01/2011 - 06/2006
2InterleukinsIBA
11/2009 - 01/2008
2DNA (Deoxyribonucleic Acid)IBA
01/2007 - 08/2005
2Tumor Biomarkers (Tumor Markers)IBA
08/2005 - 07/2004
1Epidermal Growth Factor (EGF)IBA
05/2024
1trastuzumab deruxtecanIBA
05/2024
1pegylated granulocyte colony-stimulating factorIBA
03/2024

Therapy/Procedure

27Therapeutics
05/2024 - 08/2006
15Drug Therapy (Chemotherapy)
05/2024 - 01/2006
6Transplantation
04/2024 - 01/2004
3Immunotherapy
11/2023 - 01/2012
3Heterologous Transplantation (Xenotransplantation)
08/2006 - 11/2002
2Drug Tapering
03/2024 - 08/2008
2Genomic Medicine
12/2022 - 07/2021
2Cell- and Tissue-Based Therapy (Cell Therapy)
01/2012 - 04/2003
1Castration
03/2024
1Endoscopes
01/2024
1Neoadjuvant Therapy
11/2023
1Salvage Therapy
10/2023